Investor mix
18 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 44% |
| Private equity | 1 | 6% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 7 | 39% |
Developer of therapeutics for severe respiratory diseases
18 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 44% |
| Private equity | 1 | 6% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 7 | 39% |